Clinical Trials Logo

Filter by:
NCT ID: NCT03272217 Terminated - Clinical trials for Urothelial Carcinoma

Atezolizumab With Bevacizumab in Previously Untreated Metastatic/Unresectable Urothelial Cancer

Start date: September 13, 2017
Phase: Phase 2
Study type: Interventional

This is a phase II study assessing the activity of bevacizumab combined with atezolizumab in metastatic urothelial carcinoma patients who are ineligible for cisplatin-based therapy.

NCT ID: NCT03271801 Terminated - Obesity, Childhood Clinical Trials

Skills Training Within a Family-based Obesity Treatment Intervention

Start date: June 1, 2016
Phase: N/A
Study type: Interventional

This study is investigating the impact of a skills training program in stimulus control of meals and snacks on zBMI. Participants will be randomized to a standard family-based obesity treatment intervention with education on child health or a standard family-based obesity treatment intervention with experiential learning about meal stimulus control strategies.

NCT ID: NCT03271580 Terminated - Diabetes Mellitus Clinical Trials

Biofilm Modified Macrophage Phenotype and Function in Diabetic Wound Healing

Start date: February 1, 2020
Phase:
Study type: Observational

The purpose of this study is to learn more about biofilm and to see how it affects diabetic wounds. A biofilm can occur if a chronic infection causes bacteria to grow in a slime enclosed group. This grouping of bacteria is called a biofilm.

NCT ID: NCT03270709 Terminated - Clinical trials for Vitamin D Deficiency

Effect of High-Dose Vitamin D3 in Smokers and Non-Smokers With and Without HIV

Start date: April 11, 2018
Phase: Phase 1
Study type: Interventional

Supplementation with vitamin D improves HIV+ macrophages phagocytosis in vitro. There is evidence to suggest that administering vitamin D can in fact improve immune function in individuals. The study will evaluate the impact of high dose vitamin D in HIV+ smokers' and HIV- smokers' in vivo. The primary goal is to improve innate immune host response to infection in patients already at high risk by virtue of HIV and smoking status.

NCT ID: NCT03269968 Terminated - Obesity, Morbid Clinical Trials

Use of Negative Pressure Wound Therapy in Morbidly Obese Women After Cesarean Delivery

Start date: October 3, 2017
Phase: N/A
Study type: Interventional

Obese women are more likely have a cesarean delivery and develop subsequent wound complications than normal weight women. Negative pressure wound therapy (NPWT) has been shown to improve surgical wound healing, but this device has not been adequately studied in cesarean deliveries. The aim of our study is to determine the efficacy of NPWT in morbidly obese women after cesarean delivery. Investigators will be randomizing women with a BMI > 40 kg/m2 in a 1:1 ratio to either NPWT (the PREVENA Incision management therapy system Pre 1001 Us) or standard dressing after their cesarean delivery at MedStar Washington Hospital Center. The NPWT will be left in place for a minimum of four days but not to exceed seven days. The standard dressing is typically removed on postoperative day one or two. The primary outcome is a wound complication defined as the formation of a wound infection, seroma, hematoma, separation, or dehiscence from delivery to 4 weeks postpartum. Investigators will also administer a patient satisfaction survey regarding their wound healing experience.

NCT ID: NCT03269695 Terminated - Ulcerative Colitis Clinical Trials

Efficacy, Safety and Tolerability of PF-06687234 as Add-on Therapy to Infliximab in Active UC Subjects Not in Remission.

Start date: December 20, 2017
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine if PF-06687234 is effective and safe as add-on therapy to infliximab in subjects with active ulcerative colitis who are not in remission.

NCT ID: NCT03269552 Terminated - Clinical trials for Recurrent Marginal Zone Lymphoma

Carfilzomib With or Without Rituximab in the Treatment of Waldenstrom Macroglobulinemia or Marginal Zone Lymphoma

Start date: December 18, 2017
Phase: Phase 2
Study type: Interventional

This phase II trial studies how well carfilzomib with or without rituximab work in treating patients with Waldenstrom macroglobulinemia or marginal zone lymphoma that is previously untreated, has come back, or does not respond to treatment. Carfilzomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as rituximab, may induce changes in body's immune system and may interfere with the ability of tumor cells to grow and spread. Giving carfilzomib alone when disease is responding or with rituximab when disease is not responding may work better in treating patients with Waldenstrom macroglobulinemia or marginal zone lymphoma.

NCT ID: NCT03269409 Terminated - Osteonecrosis Clinical Trials

Use of Adipose Derived Regenerative Cells in Bilateral Femoral Head Osteonecrosis

Start date: November 15, 2017
Phase: Phase 1
Study type: Interventional

This randomized clinical trial aims to determine if cells from a patient's own adipose tissue is safe and capable of helping regenerate the femoral head in patients with osteonecrosis. The standard of care is known as hip decompression which simply removes dead tissue from the femoral head and creates a new cavity to be filled in by healthy bone. This trial will use hip decompression in one hip and hip decompression supplemented with adipose derived regenerative cells in patients with osteonecrosis in both of their hips.

NCT ID: NCT03268694 Terminated - Emotions Clinical Trials

Investigation of Oscillations Underlying Human Cognitive and Affective Processing Using Intracranial EEG

Start date: August 7, 2017
Phase: N/A
Study type: Interventional

Purpose: To investigate the electrophysiological correlates of human cognition and affective processing. Participants: Drug-resistant epilepsy patients undergoing epilepsy surgery cortical mapping with continuous electrocorticography (ECoG) with intracranial electrodes. Procedures (methods): Participants will perform computer-based cognitive and affective processing tasks during routine long-term monitoring. Intracranial EEG will be collected during the task

NCT ID: NCT03268278 Terminated - Postoperative Pain Clinical Trials

Efficacy of Buprenorphine on Postoperative Endodontic Analgesia

EBPEA
Start date: April 1, 2017
Phase: Phase 1
Study type: Interventional

To see whether the addition of buprenorphone to local anesthesia will lengthen postoperative analgesia for endodontic pain